These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18501774)

  • 1. Prognostic and predictive markers in glioma and other neuroepithelial tumors.
    Rivera AL; Pelloski CE; Sulman E; Aldape K
    Curr Probl Cancer; 2008; 32(3):97-123. PubMed ID: 18501774
    [No Abstract]   [Full Text] [Related]  

  • 2. Global histone modification patterns as prognostic markers to classify glioma patients.
    Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 identified as a prognostic factor for glioma patients.
    Engh JA
    Neurosurgery; 2011 Jun; 68(6):N22-3. PubMed ID: 21778948
    [No Abstract]   [Full Text] [Related]  

  • 4. An introduction to molecular analysis and characterization of gliomas.
    Ausman JI
    Surg Neurol; 2005 Oct; 64(4):285. PubMed ID: 16181992
    [No Abstract]   [Full Text] [Related]  

  • 5. Glioma diagnosis: immunohistochemistry and beyond.
    Dunbar E; Yachnis AT
    Adv Anat Pathol; 2010 May; 17(3):187-201. PubMed ID: 20418673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standards, guidelines, and options in the treatment of glial tumors of the brain in adults].
    Konovalov AN; Potapov AA; Loshakov VA; Oliushin VE; Kornienko VN; Iartsev VV; Pronin IN; Korshunov AG; Golanov AV; Kobiakov GL; Mariashev SA; Zelenkov PA
    Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):3-11. PubMed ID: 16827422
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
    Wen PY; Reardon DA
    Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain tumor stem cells.
    Sulman E; Aldape K; Colman H
    Curr Probl Cancer; 2008; 32(3):124-42. PubMed ID: 18501775
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers and cancer stem cells in primary brain tumors. Foreword.
    Bogler O; Sawaya R
    Curr Probl Cancer; 2008; 32(3):95-6. PubMed ID: 18501773
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker.
    Laggner U; Pipp I; Budka H; Hainfellner JA; Preusser M
    Histopathology; 2007 Jun; 50(7):949-52. PubMed ID: 17543088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytogenetic diagnosis of brain tumors].
    Tabuchi K; Fukuyama K; Mineta T
    No To Shinkei; 1992 Oct; 44(10):871-9. PubMed ID: 1285987
    [No Abstract]   [Full Text] [Related]  

  • 13. Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ.
    Ludwig N; Keller A; Comtesse N; Rheinheimer S; Pallasch C; Fischer U; Fassbender K; Steudel WI; Lenhof HP; Meese E
    Clin Cancer Res; 2008 Aug; 14(15):4767-74. PubMed ID: 18676746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic clinicopathobiological grouping/staging system for gliomas: proposal of the Indian TNM subcommittee on brain tumors.
    Gupta T; Sarin R; Jalali R; Sharma S; Kurkure P; Goel A
    Neurol India; 2009; 57(3):247-51. PubMed ID: 19587462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.
    Mason WP; Cairncross JG
    Neurology; 2008 Jul; 71(5):365-73. PubMed ID: 18663182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers.
    Huttner A
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):715-32. PubMed ID: 22794280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments and controversies in the neuropathology of malignant gliomas.
    Wiestler OD; Schmidt MC; von Deimling A; Reifenberger G; Deckert-Schlüter M; Radner H; Pietsch T
    Front Radiat Ther Oncol; 1999; 33():123-38. PubMed ID: 10549483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution of immunoregulatory carbohydrate lectin receptors on glioma cell membranes and autologus peripheral mononuclears in neuro-oncological patients depending upon the degree of brain tumor anaplasia].
    Gnedkova IA; Licianyi' NI; Romodanov SA; Glavatskii' AI; Brodskaia IA; Shmeleva AA; Gerasenko KM; Khmel'nitskii' GV
    Biull Eksp Biol Med; 1996 Oct; 122(10):441-5. PubMed ID: 9081446
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroimaging.
    Henson JW; Gonzalez RG
    Handb Clin Neurol; 2012; 104():109-26. PubMed ID: 22230438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.